These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 20122172)

  • 21. A hybrid protein comprising ATF domain of pro-UK and VAS, an angiogenesis inhibitor, is a potent candidate for targeted cancer therapy.
    Sun Q; Xu Q; Dong X; Cao L; Huang X; Hu Q; Hua ZC
    Int J Cancer; 2008 Aug; 123(4):942-50. PubMed ID: 18528863
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A cell penetrating peptide derived from azurin inhibits angiogenesis and tumor growth by inhibiting phosphorylation of VEGFR-2, FAK and Akt.
    Mehta RR; Yamada T; Taylor BN; Christov K; King ML; Majumdar D; Lekmine F; Tiruppathi C; Shilkaitis A; Bratescu L; Green A; Beattie CW; Das Gupta TK
    Angiogenesis; 2011 Sep; 14(3):355-69. PubMed ID: 21667138
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via downregulating angiogenic factors of endothelial cells.
    Ao Z; Yu S; Qian P; Gao W; Guo R; Dong X; Xu J; Zhang R; Jiang C; Ji F; Qian G
    Biomed Pharmacother; 2017 Mar; 87():539-547. PubMed ID: 28081464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Suppression of tumor growth by novel peptides homing to tumor-derived new blood vessels.
    Asai T; Nagatsuka M; Kuromi K; Yamakawa S; Kurohane K; Ogino K; Tanaka M; Taki T; Oku N
    FEBS Lett; 2002 Jan; 510(3):206-10. PubMed ID: 11801255
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
    Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
    Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The C-terminal domain of canstatin suppresses in vivo tumor growth associated with proliferation of endothelial cells.
    He GA; Luo JX; Zhang TY; Hu ZS; Wang FY
    Biochem Biophys Res Commun; 2004 May; 318(2):354-60. PubMed ID: 15120609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor.
    Soto-Pantoja DR; Menon J; Gallagher PE; Tallant EA
    Mol Cancer Ther; 2009 Jun; 8(6):1676-83. PubMed ID: 19509262
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SKLB610: a novel potential inhibitor of vascular endothelial growth factor receptor tyrosine kinases inhibits angiogenesis and tumor growth in vivo.
    Cao ZX; Zheng RL; Lin HJ; Luo SD; Zhou Y; Xu YZ; Zeng XX; Wang Z; Zhou LN; Mao YQ; Yang L; Wei YQ; Yu LT; Yang SY; Zhao YL
    Cell Physiol Biochem; 2011; 27(5):565-74. PubMed ID: 21691074
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Soluble fms-like tyrosine kinase-1-enriched exosomes suppress the growth of small cell lung cancer by inhibiting endothelial cell migration.
    Hao D; Li Y; Zhao G; Zhang M
    Thorac Cancer; 2019 Oct; 10(10):1962-1972. PubMed ID: 31441580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of lysine acetyltransferases impairs tumor angiogenesis acting on both endothelial and tumor cells.
    Di Martile M; Gabellini C; Desideri M; Matraxia M; Farini V; Valentini E; Carradori S; Ercolani C; Buglioni S; Secci D; Andreazzoli M; Del Bufalo D; Trisciuoglio D
    J Exp Clin Cancer Res; 2020 Jun; 39(1):103. PubMed ID: 32498717
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of adrenomedullin on endothelial cells in the multistep process of angiogenesis: involvement of CRLR/RAMP2 and CRLR/RAMP3 receptors.
    Fernandez-Sauze S; Delfino C; Mabrouk K; Dussert C; Chinot O; Martin PM; Grisoli F; Ouafik L; Boudouresque F
    Int J Cancer; 2004 Mar; 108(6):797-804. PubMed ID: 14712479
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A novel FGFR1-binding peptide exhibits anti-tumor effect on lung cancer by inhibiting proliferation and angiogenesis.
    Tan Q; Wang Z; Wang Q; Wang Y; Huang Z; Su N; Jin M; Kuang L; Qi H; Ni Z; Li C; Zhu Y; Jiang W; Chen H; Deng C; Du X; Xie Y; Chen L
    Int J Biol Sci; 2018; 14(10):1389-1398. PubMed ID: 30123084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An Anti-Cancer Peptide LVTX-8 Inhibits the Proliferation and Migration of Lung Tumor Cells by Regulating Causal Genes' Expression in p53-Related Pathways.
    Zhang P; Yan Y; Wang J; Dong X; Zhang G; Zeng Y; Liu Z
    Toxins (Basel); 2020 Jun; 12(6):. PubMed ID: 32498425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The anti-tumor properties of two tumstatin peptide fragments in human gastric carcinoma.
    Li YJ; Sun LC; He Y; Liu XH; Liu M; Wang QM; Jin XM
    Acta Pharmacol Sin; 2009 Sep; 30(9):1307-15. PubMed ID: 19701238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dual-function synthetic peptide derived from BMP4 for highly efficient tumor targeting and antiangiogenesis.
    Choi SH; Lee JY; Suh JS; Park YS; Chung CP; Park YJ
    Int J Nanomedicine; 2016; 11():4643-4656. PubMed ID: 27695323
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
    Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
    Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of human cripto-1 in tumor angiogenesis.
    Bianco C; Strizzi L; Ebert A; Chang C; Rehman A; Normanno N; Guedez L; Salloum R; Ginsburg E; Sun Y; Khan N; Hirota M; Wallace-Jones B; Wechselberger C; Vonderhaar BK; Tosato G; Stetler-Stevenson WG; Sanicola M; Salomon DS
    J Natl Cancer Inst; 2005 Jan; 97(2):132-41. PubMed ID: 15657343
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery.
    Lee TY; Lin CT; Kuo SY; Chang DK; Wu HC
    Cancer Res; 2007 Nov; 67(22):10958-65. PubMed ID: 18006841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Distinct antitumor properties of a type IV collagen domain derived from basement membrane.
    Maeshima Y; Colorado PC; Torre A; Holthaus KA; Grunkemeyer JA; Ericksen MB; Hopfer H; Xiao Y; Stillman IE; Kalluri R
    J Biol Chem; 2000 Jul; 275(28):21340-8. PubMed ID: 10766752
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recombinant canstatin inhibits angiopoietin-1-induced angiogenesis and lymphangiogenesis.
    Hwang-Bo J; Yoo KH; Park JH; Jeong HS; Chung IS
    Int J Cancer; 2012 Jul; 131(2):298-309. PubMed ID: 21823121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.